Authors' recommendations: Description of Technology: Although positron emission tomography (PET) provides information about glucose metabolism, cellular proliferation, and cellular receptor expression, it has limited spatial resolution. Hybrid PET/magnetic resonance imaging (MRI) scanners have recently become available. Compared with PET combined with computed tomography (CT), PET/MRI offers less exposure to ionizing radiation and the ability to study dynamic contrast enhancement. PET and MRI both provide physiological, cellular, and molecular information about the tissues imaged. The anatomical information provided by MRI is superior to that available with CT in soft tissues, and MRI may be superior for detecting metastases in the liver, brain, and bone marrow. Combining PET and MRI technologies using a hybrid technique permits simultaneous acquisition of data and reduced scanning time, and increases patient convenience. Patient Population: Breast cancer staging with PET/MRI is intended for patients with an initial diagnosis of breast cancer and patients who require restaging after treatment or recurrence of breast cancer.

Project Status: Completed

Year Published: 2016

URL for published report: The report may be purchased from: http://www.hayesinc.com/hayes/crd/?crd=40586

English language abstract: An English language summary is available

Publication Type: Not Assigned

Country: United States

Organisation Name: HAYES, Inc.

Contact Address: 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218

Contact Name: saleinfo@hayesinc.com

Contact Email: saleinfo@hayesinc.com

Copyright: 2014 Winifred S. Hayes, Inc